[BIOMARKERS OF EARLY AND DIFFERENTIAL DIAGNOSIS OF PROSTATIC CANCER].

There were examined 87 patients, suffering prostatic gland diseases, in whom the level of general prostate-specific antigen (PSA) in the blood have constituted 0.5 – 30 ng/ml. In 27 of them prostatic gland diseases were not revealed, in 28 – prostatic cancer was diagnosed, and in 32 – benign prostatic hyperplasia. There was proved, that rate of prostatic cancer and benign prostatic hyperplasia have correlated with prostatic gland volume and depended upon PSA and its isoforms concentration in the blood. The [-2] proPSA in the blood serum level have differed in all three groups, and the level of general and free PSA – in patients of group I, comparing with that in the groups 2 and 3. That have witnessed the possibility of determining of the [-2]proPSA content as alternative biomarker of early and differential diagnosis of prostatic cancer.

Klinichna khirurhiia. 0000 Jan [Epub]

V M Grygorenko, R O Danylets, M V Vikarchuk, L V Gorbahn, A V Klepko

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe